... 960–976 Surgical Treatmentof PD 41 SurgicalTreatmentof Parkinson’s Disease Past, Present, and Future William C Koller, Alireza Minagar, Kelly E Lyons, and Rajesh Pahwa PAST Neurosurgical ... Collateralization of Striatofugal Neurons and Co-localization of Dopamine Receptors One of the important series of data that challenged the concept of segregated direct and indirect striatofugal pathways ... gathered a group of experienced and recognized authorities in the field who have provided authoritative reviews that define the current state of the art ofsurgicaltreatmentof Parkinson’s disease and...
... limitation in the assessment ofcoronaryartery disease, since finding of regional differences is more important than absolute values Methodological limitations of strain rate imaging Since strain ... time integral of strain rate, most often using end-diastole as reference, and is a dimensionless quantity [5] In clinical terms strain repre- Tissue Doppler imaging and coronaryarterydisease Smiseth ... reflection of the early systolic lengthening, which is a hallmark of severe ischemia Penicka et al [18] tested the ability of IVC velocities to predict recovery of myocardial function after coronary...
... 1.1 Overview ofcoronaryarterydisease 1.2 Overview of the epidemiology ofcoronaryarterydisease 1.3 Overview of the etiology ofcoronaryarterydisease 1.4 Research ... Overview ofcoronaryarterydiseaseCoronaryarterydisease (CAD) is the most common type of heart disease and the number two killer of death after cancer It is characterized by the blockage ofcoronary ... imperative that studies ofcoronaryarterydisease in Asia are conducted to address this increasing burden 1.3 Overview of the etiology ofcoronaryarterydisease The etiology of CAD is multifactorial,...
... Summary viii List of Publications x List of Abbreviations xi List of Tables xiv List of Figures xv Introduction to CoronaryArteryDisease 1.1 Definition ofcoronaryarterydisease ... Genetic basis ofcoronaryarterydisease 14 1.6.1 Genetic markers for coronaryarterydisease risk 14 1.6.2 Ethnic variation of prevalence and mortality of CAD 15 1.6.3 ... Cumulative age distribution of mt5178C and mt5178A subjects 65 xv Chapter Introduction to CoronaryArteryDisease 1.1 Definition ofcoronaryarterydisease Ischemic heart disease is the generic...
... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronaryartery a Indicates patients who received ... encapsulated stent for treatmentof native coronaryartery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation, 2006; 114: 798–806 Kandzari DE, Leon MB Overview of pharmacology ... is safe and reduces the rates of clinical and angiographic restenosis in patients with symptomatic coronaryarterydisease (CAD; 4) Also the safety and efficacy of Paclitaxel-eluting stent (PES;...
... coronaryarterydisease that was treated with either the SES or the PES METHODS Patient Population The study population consisted of 204 consecutive series of all patients who had undergone coronary ... (11) C 42 (41) 41 (41) Site of Lesion Treated, No (%) Type of lesion, No (%) Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ... for enrollment if there was symptomatic coronaryarterydisease or positive functional testing, and angiographic evidence of a target lesion stenosis of ≥ 70% in a ≥ 2-mm vessel Patients with...
... and Pathophysiology ofCoronaryArteryDisease Epidemiology ofCoronaryArteryDisease John F Beltrame, Rachel Dreyer and Rosanna Tavella Discipline of Medicine, University of Adelaide, The Queen ... epidemiology ofcoronaryarterydiseaseCoronaryarterydisease (CAD) is the global leading cause of death and may manifest clinically as an acute coronary syndrome such as AMI, or a chronic coronary ... total of 88,000 CAD deaths (15% of total deaths) (British Heart Epidemiology ofCoronaryArteryDisease *Source World Health Organisation, Global Burden ofDisease 2004 Update Fig Distribution of...
... http://www.translational-medicine.com/content/7/1/42 Effects of platelet inhibiting treatment in coronaryarterydisease When investigating possible effects of platelet-inhibiting treatment with Repeated Measures ANOVA, ... number not for citation purposes) Journal of Translational Medicine 2009, 7:42 One of the controls was excluded because of intake of NSAIDs meaning that a total of 29 controls, 19 males and 10 females, ... control means of visit and and treatment with ASA (A), clopidogrel (C) and the combination of ASA and clopidogrel (A+C) The respective figures show the effect of platelet inhibiting treatment on...
... Patients with coronaryarterydisease (CAD) and refractory or recurrent retrosternal symptoms have a reduction in life expectancy and HRQL compared to patients with stable coronaryarterydisease [4-7] ... quality of life; CAD: coronaryartery disease; GER: gastroesophageal reflux; PPI: proton pump inhibitors; HRQLRAD: Quality of Life in Reflux and Dyspepsia questionnaire; AF: HRQL: Quality of Life ... Majer M, ąwiątkowski M: The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronaryartery disease- a randomised, double-blind,...
... [11,18,19] In such cases, surgicaltreatment consists of excision of the sac and replacement of the graft using a new synthetic graft or an umbilical vein or homograft iliac artery [17,19] Conservative ... Department, University of Patras, School of Medicine, Patras, Greece, 2Department of Interventional Radiology, University of Patras, School of Medicine, Patras, Greece and 3Department of Anaesthesiology ... successful in only 65-70% of cases, due to high rates of recurrence and infection [16] In contrast, surgical management with replacement of the graft and radical excision of the sac has a cure rate...
... Mendeloff EN: Reappraisal ofcoronary endarterectomy for the treatmentof diffuse coronaryarterydisease Ann Thoracic Surg 1999, 68:1272-7 Nishi H, Miyamoto S, Takanashi S: Optimal method ofcoronary ... Endarterectomy in the treatmentofcoronaryarterydisease J Thoracic and Cardiovasc Surg 1964, 47:98 Dilley RB, Cannon JA, Kattus AA: The treatmentofcoronary occlusive disease by endarterectomy ... Early results ofcoronary endarterectomy are acceptable with respect to mortality, NYHA & CCS This technique offers a valuable surgical option for patients with endstage coronaryarterydisease in...
... reduction of cardiac events with Perindopril in stable coronaryArterydisease Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronaryartery disease: ... Soumerai SB: Undertreatment of hyperlipidemia in the secondary prevention ofcoronaryarterydisease J Gen Intern Med 1999, 14:711-717 Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta-blockade ... section, treatmentof acute MI, and treatmentof unstable angina) A tenth trial evaluated the impact of a multifaceted intervention that included physician and nurse opinion leaders (as two of the...
... Patients with coronaryarterydisease (CAD) and refractory or recurrent retrosternal symptoms have a reduction in life expectancy and HRQL compared to patients with stable coronaryarterydisease [4-7] ... quality of life; CAD: coronaryartery disease; GER: gastroesophageal reflux; PPI: proton pump inhibitors; HRQLRAD: Quality of Life in Reflux and Dyspepsia questionnaire; AF: HRQL: Quality of Life ... Majer M, ąwiątkowski M: The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronaryartery disease- a randomised, double-blind,...
... Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronaryarterydisease in systemic lupus erythematosus: a prospective proof -of- concept ... atherosclerosis, coronaryartery disease, risk factors Introduction Systemic lupus erythematosus (SLE) is associated with a dramatically increased risk of atherosclerotic coronaryarterydisease (CAD) ... at the level of the heart Korotkoff phase V (disappearance) was recorded as DBP Calculation of ‘summary measures’ of TC, SBP and DBP For each of TC, SBP and DBP, an arithmetic mean of all available...
... Atherogenic effects of A-SAA 2.2.9 Atheroprotective effects of A-SAA 2.2.10 Role of A-SAA in other chronic inflammatory diseases 2.3 Genetic Analysis of Complex Diseases 2.3.1 Complex Diseases 2.3.2 ... analysis of complex disease is, however, limited by the polygenic 27 nature of such disease The polygenic nature of complex disease implies that each allele might have subtle effects on disease ... REVIEW 2.1 Atherosclerosis and coronaryarterydisease (CAD) 2.1.1 Atherosclerosis – a chronic inflammatory disease 2.1.2 Pathogenesis of atherosclerosis and acute coronary syndrome 2.1.3 Risk...
... STUDIES OF COMMON VARIATIONS IN TWO CANDIDATE GENES OF DYSLIPIDEMIA AND CORONARYARTERYDISEASE HE XUELIAN (BACHELOR OF MEDICINE) A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ... REVIEW…………………………………………………………… 2.1 Coronaryarterydisease (CAD)………………………………………………… 2.1.1 Definition of CAD………………………………………………………… 2.1.2 Prevalence of CAD………………………………………………………… 2.1.3 Pathophysiology and pathogenesis of CAD………………………………… ... principle of the DHPLC 20 Figure 4-1 DHPLC profiles of ACAT2 polymorphisms 75 Figure 4-2 DNA sequencing results of ACAT2 polymorphisms detected in 76-77 this study Figure 4-3 DHPLC profile of ACAT2...
... to CoronaryArteryDisease Chapter Introduction to CoronaryArteryDisease Chapter1: Introduction to CoronaryArteryDisease 1.1 Definition ofcoronaryartery disease( CAD) Coronaryarterydisease ... II Summary List of Tables List of Figures List of Abbreviations Chapter 1: Introduction 1.1 Definition ofCoronaryArteryDisease (CAD) 1.2 Prevalence of CAD 1.3 Pathogenesis of CAD 10 1.4 Conventional ... Introduction to CoronaryArteryDisease heart diseases have the advanced coronary atherosclerosis with one or more stenotic lesions causing at least 75% reduction of the cross sectional area of at least...